seed
Stage
1
Investors
About
Mimio develops a fasting mimetic supplement designed to replicate the cellular health benefits of a 36-hour fast without requiring actual fasting, using bioactive metabolites to support metabolism, longevity, and overall cellular health.
Explore Mimio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.